Using oncolytic viruses to deliver genes for treating high-grade gliomas
Oncolytic virus bispecific gene delivery for high grade gliomas
This study is exploring a new way to treat aggressive brain tumors in kids by using special viruses that can target and destroy cancer cells, while also boosting the body's immune system to help fight the cancer better, and some patients may have the chance to try these exciting new treatments in clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10832350 on NIH RePORTER |
What this research studies
This research focuses on developing a novel approach to treat high-grade gliomas, particularly in pediatric patients, by utilizing oncolytic viruses that can selectively target and kill cancer cells. The project aims to enhance the immune response against tumors by delivering specific genes that can improve the effectiveness of existing therapies. Through a combination of innovative techniques, the research seeks to overcome barriers in current cancer treatments and harness both innate and adaptive immunity to fight these aggressive tumors. Patients may be involved in clinical trials that test these new therapies, providing them with access to cutting-edge treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are pediatric patients diagnosed with high-grade gliomas who have limited treatment options.
Not a fit: Patients with low-grade gliomas or those who have already received extensive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for high-grade gliomas, potentially improving survival rates and quality of life for affected patients.
How similar studies have performed: Other research has shown promise in using oncolytic viruses for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Cripe, Timothy P — Research Inst Nationwide Children's Hosp
- Study coordinator: Cripe, Timothy P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.